Biography
Dr. Xiaoshan “Shirley” Shi is a Microbiologist and Immunologist with strong background in tumor immunology and host-pathogen interactions. She acquired her doctorate degree in Microbiology from New York University Medical Center, where she studied the mechanism of the copper homeostasis in Mycobacterium tuberculosis (Mtb). To expand her knowledge in Immunology, she did her postdoctoral training in Cedars-Sinai Medical Center, where she studied the immune response to both cancer development and infections. Dr. Shi is currently working for department of Immuno-Oncology, MedGenome Inc, US. She is setting up dendritic cell-T cell co-culture assays to screen patient tumor-derived peptides for cancer vaccines. Using a variety of molecular, cellular and bioinformatical approaches, she is trying to understand how the cancer vaccines stimulate the immune system to control tumor development in patients.
Interests
Bacteria pathogenesis, tumor immunology, microbiome, host-pathogen interactions, cancer vaccine, immunotherapy.
+1 249-493-6904
